CAMP4 Therapeutics Corporation has reported progress on its clinical programs and financial results for the first quarter of 2025. The ongoing Phase 1 trial of CMP-CPS-001 for Urea Cycle Disorders has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback